The US Food and Drug Administration on Friday approved the use of a human papillomavirus vaccine called Gardasil 9 for men and women between the ages of 27 and 45. The FDA previously approved the HPV vaccine for people age 9 to 26.
Women over 30 years old have a new option when it comes to screening for cervical cancer, according to guidelines released Tuesday by the U.S. Preventive Services Task Force and published in the journal JAMA.
A vaccine against the human papillomavirus, or HPV, will be given to boys in England for the first time, the UK government announced on Tuesday.
Cervical cancer is among the easiest gynecologic cancers to prevent, and two screening tests can help detect the disease early: the routine Pap smear and testing for human papillomavirus, or HPV.
The introduction of HPV vaccines has led to a sharp reduction in the number of young women with the cancer-causing infection in England, new data from Public Health England finds.
The human papillomavirus or HPV spreads through intimate contact during sex with someone who is infected. In some women, an HPV infection will persist and lead to cervical cancer. HPV vaccines protect against cervical cancer in young women, especially when the women are vaccinated between the ages of 15 and 26, a new Cochrane Report finds.
The thought of a vaccine might conjure up memories of that flu shot you get each year, or taking your kids to get their immunizations against polio or measles. Cancer rarely comes to mind when most people think of vaccines, but that appears to be changing.
